CIIE 2022 will Host 14 Brazilian Food and Beverage Companies

HONG KONG, Nov 5, 2022 – (ACN Newswire) – The Brazilian Trade and Investment Promotion Agency (ApexBrasil) is coordinating Brazilian companies' participation in the China International Import Expo (CIIE), one of the largest multi-sector trade shows in China. This year the Agency is in charge of organizing individual booths for 14 companies at the food and beverage pavilion.

The event is a great opportunity for Brazilian companies to develop new contacts and relationships with specialized professionals and potential business partners, as well as introduce their products to the Chinese public. Due to the Covid-19 pandemic travel restrictions, most Brazilian companies will participate through local their representatives.

In addition to individual booths, on-site exhibitors will have access to a fully equipped kitchen, a meeting room and a sample storage room. The agenda also includes a 'Brazil Coffee Day', organized in partnership with the Brazilian Consulate in Shanghai and the 'Brazil Cooking Show'.

For the first time, the CIIE is providing e-CIIE 2022, a digital platform for participants. The platform includes four major sections: showroom, news release, live streaming and matching exhibitors and buyers. Mofocom China invited ApexBrasil to oversee the Brazil National Pavilion section of the e-CIIE 2022. ApexBrasil is also supporting the Consulate General of Brazil in Shanghai to set up the Brazil High Tech pavilion at the trade show. The pavilion will showcase exhibitors from 19 high tech startups.

China is Brazil's main trading partner, accounting for 31.3% of Brazil's exports and 21.7% of its imports in 2021. Trade between the two nations reached an historic record of US$ 135.5 billion in 2021, with Brazil recording a surplus of US$ 40.25 billion. That same year, Brazilian food and beverages exports to China totaled US$ 8.17 billion. The main products in the sector's export list were beef, sugars and molasses, and pork.

CIIE
The CIIE (China International Import Export) is the first national import fair in the world. It has been held by the Chinese government annually since 2018. The first edition of the event held in 2018 was attended by more than 100 countries and 150,000 buyers. In 2019, more than 500,000 visitors, 3,800 exhibitors and 700 media outlets participated.

SERVICE
EVENT: China International Import Expo (CIIE)
DATE: November 5th to 10th
WHERE: Shanghai, China


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation

YANGON, Myanmar, Nov 5, 2022 – (ACN Newswire) – AW Foundation, the philanthropic arm of Asia World Group of Companies, handed over to the Ministry of Health the newly completed Wai Bar Gi New Wing – National Centre for Infectious Diseases on 3rd Nov, 2022. Dedicated to the treatment of infectious diseases and pandemics such as COVID-19 which exerted heavy patient load on the public healthcare sector, it is the most advanced medical centre to date in Myanmar.


The Newly-Constructed Wai Bar Gi New Wing- National Centre for Infectious Diseases

Side Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases

Interior Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases


Lieutenant General Aung Lin Dwe, the secretary of the State Administration Council, unveiled a plaque commemorating the handover of the three-story, 110-bed medical Centre, which was completed with a donation of 6 billion kyats and USD 3.1 million from the Foundation.

The Wai Bar Gi New Wing was mooted in November 2020 by the AW Foundation team based on the personal experience of colleagues during the COVID-19 pandemic. The lack of quarantine hospitals, beds, and oxygen supply, and critically, the exposure of the devoted medical frontliners taking care of patients in general hospitals were gaps in the healthcare system evidenced during the critical period.

The 51,055 square feet (4,745sqm) Centre is equipped with airflow control (negative-positive pressure), integrated oxygen access, isolation rooms, and water treatment and features that combine to make it one of the most technologically-advanced public healthcare facilities in the country. AW Foundation believes the new Centre will support the public healthcare system for the treatment of COVID-19 and any future pandemic.

Construction of Centre

A ground-breaking ceremony was held on-site on 5 January 2021. Construction was delayed due to a nationwide lockdown arising from the pandemic.

The Centre is equipped with:

– Donning and Doffing for medical staff
– Staff corridors and lifts for use by Patients and Staff
– Air-Conditioning and Mechanical Ventilation (ACMV) for full-time automatic disinfection of the air-flow system in the hospital building
– Room communication systems and other electrical communication facilities (PABX, PA & Intercom)
– Sound-Proof Generator for emergency use
– Emergency response alarm systems that can automatically respond to fire and various natural disasters (fully equipped as required for an infectious disease treatment hospital)

Sustainable Garden Hospital

The Centre was conceptualized and constructed with deep consideration of the environment. Sustainable solar energy and the creation of new greenery at the Centre also create an environment to enhance the recovery process of patients and the well-being of the healthcare community.

About AW Foundation (AWF) – Together, we can make change happen

AW Foundation is a non-profit organization and the philanthropic arm of the Asia World Group of Companies. AWF supports projects that develop the well-being of the people of Myanmar, focusing on healthcare, education, disaster relief, and community development. It was established in 2014, building on a strong tradition of philanthropy of the Asia World Group of companies since 1992.

AW Foundation aims to develop and advance the livelihoods of people throughout Myanmar and is passionate about exploring new projects that benefit all.

Through our commitment to quality and continued efforts to help those in need, AWF strives to deliver exceptional value and improve the lives of Myanmar's citizens. https://aw-foundation.org/

For media queries, please contact the AW Media Office at media@aw-foundation.org

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

JE Cleantech Holdings Limited Announces Receipt of NASDAQ Notification Regarding Minimum Bid Price Deficiency

SINGAPORE, Nov 4, 2022 – (ACN Newswire) – JE Cleantech Holdings Limited (Nasdaq: JCSE), a manufacturer of a broad range of cleaning systems, announced that on November 3, 2022, it received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (the "Nasdaq Notification"). The Notification stated that the Company's ordinary shares failed to maintain a minimum bid price of $1.00 over the last 30 consecutive business days as required by Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). Receipt of the Nasdaq Notification does not result in the immediate delisting of the Company's ordinary shares and has no immediate effect on the listing or the trading of the Company's ordinary shares on the Nasdaq Capital Market under the symbol "JCSE".

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days from the date of the Nasdaq Notification, or until May 2, 2023, to regain compliance with the Minimum Bid Requirement. If at any time before May 2, 2023 the closing bid of the Company's ordinary shares is at least $1.00 for a minimum of 10 consecutive business days, the Company will be deemed to have regained compliance with the Minimum Bid Requirement following which Nasdaq will provide a written confirmation of compliance and the matter will be closed.

In the event that the Company does not regain compliance by May 2, 2023, the Company may be eligible for additional time to qualify. To qualify for additional time, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market with the exception of the bid price requirement.

In the event that the Company does not regain compliance with the Minimum Bid Price Requirement by May 2, 2023 and is ineligible for an additional grace period, Nasdaq will provide further written notice that the Company's ordinary shares are subject to delisting from The Nasdaq Capital Market. In that event, the Company may appeal the determination to a Nasdaq hearings panel or consider transferring the listing and trading of its ordinary shares to the OTCQX of the OTC Markets.

The Company intends to monitor the closing bid price of its ordinary shares. Receipt of the Nasdaq Notification has no effect on the Company's business operations.

"We are cognizant of the value to our shareholders of the listing of our shares on Nasdaq given the liquidity and pricing efficiency that the exchange provides. We pledge our best efforts towards improved performance which we believe will allow to meet the continued listing standards," stated Ms. Bee Yin Hong, CEO and Founder of JE Cleantech.

About JE Cleantech Holdings Limited

JE Cleantech Holdings Limited is based in Singapore and is principally engaged in (i) the sale of cleaning systems and other equipment; and (ii) the provision of centralized dishwashing and ancillary services. Through its subsidiary, JCS-Echigo Pte Ltd, the company designs, develops, manufactures, and sells cleaning systems for various industrial end-use applications primarily to customers in Singapore and Malaysia. Its cleaning systems are mainly designed for precision cleaning, with features such as particle filtration, ultrasonic or megasonic rinses with a wide range of frequencies, high pressure drying technology, high flow rate spray, and deionized water rinses, which are designed for effective removal of contaminants and to minimize particle generation and entrapment. The Company also has provided centralized dishwashing services, through its subsidiary, Hygieia Warewashing Pte Ltd, since 2013 and general cleaning services since 2015, both mainly for food and beverage establishments in Singapore. For more information about JE Cleantech, please visit our website: www.jecleantech.sg.

JE Cleantech Contact:
enquiry@cleantech.sg

Corporate Communications
Address
3 Woodlands Sector 1
Singapore 738361
Telephone
+65 6368 4198

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. JE Cleantech's actual results may differ from their expectations, estimates and projections and, consequently, readers should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue" and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, JE Cleantech's expectations with respect to future performance and anticipated potential financial impacts.

These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside JE Cleantech's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) dependence on our customer groups' needs and relationship with them; (2) the inability to obtain or maintain the listing of JE Cleantech Holdings Limited's ordinary shares on Nasdaq; (3) the ability of JE Cleantech to continue grow its business operations, manage growth profitably, retain its key employees and timing of meeting expected business milestones; (4) changes in applicable laws or regulations; (5) the possibility that JE Cleantech may be adversely affected by other economic, business and/or competitive factors; and (6) other risks and uncertainties identified, including those under "Risk Factors," contained in the filings with the SEC. The foregoing list of factors is not exclusive. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. JE Cleantech cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. JE Cleantech does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company

HONG KONG, Nov 4, 2022 – (ACN Newswire) – SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that, Mr. Shanchun WANG has been appointed as the President (China) of the Company. Mr. Wang will mainly be responsible for the China operation.

Mr. Shanchun WANG, served as the executive director of Sino Biopharmaceutical Limited (stock code: 1177) and the president of Chia Tai – Tianqing Pharmaceutical Group Co. Ltd., joined SinoMab lately as the President (China) of the Company. Mr. Shanchun WANG has rich experience and practical achievements in corporate strategic management, organizational management, innovation research and development and product commercialization. He is a specialist that granted the special government allowances of the State Council and awarded as a national model worker, a Jiangsu Province Technology Advanced Worker, a Jiangsu Province Model Labour, a winner of the Shanghai Technology Advancement First Honour Award, a Jiangsu Province Outstanding Entrepreneur, a Jiangsu Province Young and Middle-aged Expert with Outstanding Contribution, a Jiangsu Advanced Individual with Outstanding Contribution in Manufacture etc.

Mr. Shanchun WANG said that: "Under the leadership of Dr. Shui On LEUNG, SinoMab has gathered a very strong R&D force, forged a unique B-cell therapeutic platform, and prospectively launched a pipeline with a series of potential key products, with truly internationally recognized original innovation strength. At the same time, SinoMab's dedication to the field of autoimmune diseases and its vision of growing into a global leader in novel treatments of immunological diseases is highly consistent with the development model of my service enterprises in the past, which is also an important reason why I chose to join SinoMab."

Dr. Shui On LEUNG said that: "It is a great pleasure to have Mr. Shanchun WANG joining the Company. Our Group has been engaging extensively in the field of autoimmune disease and with the mission of growing into a global leader in the novel treatments of immunological diseases. We have a strong research and development capabilities. Leveraging on our Group's B-cell therapeutic platform, Alarmins-pathway therapeutic platform and selective T-cell therapeutic platform, the Group has a strategic plan in expanding and diversifying our product pipeline. We believe that Mr. Wang's rich experience in the pharmaceutical industry for more than 30 years, and as one of the leaders in the biotech industry in China, will help expediting the Company's development from a global drug research and development enterprise to a biopharmaceutical company bearing commercialization capabilities and international perspective. Mr. Wang's engagement as the President (China) of the Company while also subscribing shares of the Company also reflects the confidence and commitment of Mr. Wang and our senior management towards the long-term and sustainable growth of the Group, and the continuous support of our senior management will be beneficial to the long-term business development of the Group."

The Company entered into a subscription agreement with Mr. Wang earlier. Pursuant to the subscription agreement, Mr. Shanchun WANG conditionally agreed to subscribe for and the Company conditionally agreed to allot and issue 14,340,000 subscription shares. This reflects his confidence and commitment towards the long-term and sustainable growth of the Group.

About SinoMab BioScience Limited
SinoMab BioScience Limited (stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis (RA) and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), pemphigus, non-Hodgkin's lymphoma (NHL), asthma, and other diseases with major unmet clinical needs.


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

The Executive Talk by ShareInvestor: Rojukiss International PCL (SET: KISS)

BANGKOK, Nov 4, 2022 – (ACN Newswire) – Rojukiss International PCL (SET: KISS) Chief Executive Officer, Ms. Worrawan Chaikamnerd provided an admirable interview regarding her business strategy under the tough timing caused by the Covid-19 pandemic and the company's core vision reflecting future growth.


Rojukiss International PCL Chief Executive Officer, Ms. Worrawan Chaikamnerd


1. Amid the Covid-19 pandemic, what challenges have your business faced? And what is your key strategy?

The COVID-19 pandemic has been one of the major challenges for Thailand's beauty industry and our company. We must refine our strategies and business plans to cope with the ever-changing market and rapidly changing consumer behavior.

Regarding the long-term strategy, we aim to increase our top line to 3,000 million baht by 2026. Our focus remains on beauty and health products, such as skincare, makeup, hair color, and food supplements, which align with the company's vision and mission: To be Asia's leading beauty and health company by creating the best innovation to fulfil everyone's demand and inspiring people across Thailand and Asia.

2. How is your product development and business expansion plan?

The priority is to grow and strengthen our core brand – the Rojukiss brand by enhancing the product innovation. At the same time, we continue searching for opportunities to reach consumers by adjusting marketing strategies called "Beauty Convenience." Since Q1/2022, we have been trying to communicate with consumers through digital channels and leveraging data to create effective communication. All supports from our market research team provides in-depth market insights, ensuring that we proceed with the best fit consumer-based strategy.

One tactical approach we used during the pandemic was increasing product volume but maintaining the price. With this promotion, we not only added value and increased customers' access to the product but also captured profitability at a reasonable level. As a result, Rojukiss has continued to grow despite the challenging business environment amid the slow trending of Covid-19 pandemic. with a sales target of 1,000 million baht by 2024 as Rojukiss remains our powerhouse brand.

In addition, we have also attempted to push other potential brands, especially "Best Korea" brand, in which we have upgraded into new formulas and imported ingredients from abroad. The brand highlights its 'convenience to carry and use anywhere' concept because we distribute it as a sachet, which also comes up with an affordable price for everyone. Furthermore, we also launched a new product under the Best Korea umbrella, "Best Korea SSUK," targeting to teen shoppers. The company is committed to build Best Korea the Second Pillar.

Strengthen the company with health innovations

Our core vision and mission is to become Asia's leading beauty and health company by creating the best health-related innovation. Recently, we invested in Hibiocy Co., Ltd. (HIB) to expand our business into health innovations. Consequently, we were able to roll out the first product called "Vaill CoviTRAP Anti-CoV Nasal Spray", designed to suppress the COVID-19 virus physically. We received a very positive support from the market.

Expanding markets and opportunities to become Asia's leading beauty and health company

Regarding the company's long-term plan, we also search for new growth opportunities abroad. Currently, we have entered into four major countries: Indonesia and Vietnam – through the foreign distributor model, Laos and Cambodia – through the cross-broader sale model. In these markets, we found high demand for beauty and health products and similar customer behavior to that of Thai consumers. Particularly in Indonesia, after the product kicked-off, we received an impressive receptivity that exceeded our expectations.

Overall, our key strategy is to focus on developing new products, bringing out the best of Rojukiss and adjusting the products to fill the gap in consumption trends. Therefore, we must understand the consumer first, build innovative product, and find a suitable partner whose expertise could bring us into the market.

3. At the end of Q3/2022, KISS launched a new product concerning COVID-19 virus prevention. Please tell us about its specialty.

For this project, we collaborated with Faculty of Medicine at Chulalongkorn University, the Institute of Health Systems Research (HSRI), Silpakorn University, and the Government Pharmaceutical Organization (GPO) to form up the Thai medical working team to fight against COVID-19. Consequently, we successfully invented Thailand and the world's first innovation in developing a nasal spray with Monoclonal Human Antibody Cocktail technology from research on human immunity to combat and inhibit the COVID-19 virus. It is considered an advanced biological technology developed from decoding antibodies obtained from volunteers who have recovered from COVID-19 infection and have excellent immunity, which helps inhibit and prevent COVID-19 physically. Impressively, it could hinder the infection covering up to 98% of all species and last up to 6 hours.

This nasal spray works in two functions; (1) trapping the virus with the HPMC that covers the surface of the nasal cavity, which reduces the virus's ability to embed itself in the nasal cavity, and (2) excellent immunity, adopted from recovered patients (Human Monoclonal Antibodies), will inhibit and block COVID-19 entering the nasal cavity physically.

For me, this product is the pride of Thais whose breakthrough innovation could transform society. It shows our indubitable potential, which is second to none in the world.

4. What core value have you and your company employees adhered to?

As a beauty and health company, we have always committed to integrity, especially to our customers, partners, shareholders, and other stakeholders.

Honesty and integrity mean providing valuable products that serve consumers' demands at an accessible price, as well as maintaining consistent Rojukiss grade quality.

On behalf of Rojukiss International Pcl, we will continue to develop products through innovations and with latest technologies under ethical business practices and good corporate governance. All aim to orchestrate the organization to grow sustainably.

Watch Executive Talk by ShareInvestor on YouTube ShareInvestor Thailand https://www.youtube.com/c/ShareInvestorThailand

About The Executive Q&A Series

The Executive Q&A Series is presented by ShareInvestor, Asia's leading financial internet media and technology company and the largest investor relations network in the region. For more information, email admin.th@shareinvestor.com, and visit our Website: www.ShareInvestorThailand.com.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Trintech Client Serco Named Winner in 15th Annual Ventana Research Digital Leadership Awards

DALLAS, TX, Nov 3, 2022 – (ACN Newswire) – Trintech, a leading global provider of cloud-based financial close solutions for the Office of Finance, announced today that its customer, Serco, a leading provider of professional, technology, engineering and management services, has been named the winner in the "Office of Finance" category of the 15th annual Ventana Research Digital Leadership Awards. Serco's win is attributed to its innovative use of Trintech's Cadency Platform to standardize and automate its reconciliation and financial close processes.

"We want to congratulate Serco for its use of Trintech's solution in applying automation in its accounting close to speed processes in a complex business, enable staff to focus more of their time on high-value efforts and promote greater confidence in the integrity of its financial statements," remarked Robert Kugel, Senior Vice President and Research Director at Ventana Research.

Following the successful roll-out of Cadency, Serco has achieved a single, standardized approach to balance sheet management on a global scale. Reconciliations now require less manual effort thanks to increased automation and the application of a risk-based strategy. In addition, the use of a centralized global solution has provided greater insight into the total number of reconciliations performed as well as their timeliness and accuracy.

"I am honored to accept this award on behalf of the Project Team who implemented Cadency and the BAU team who continues to use and promote continuous improvement within our reconciliation process," said Paul Adams, Head of New Business & R2R at Serco. "The transformative success our team has been able to achieve with Trintech's Cadency solution has been remarkable and we look forward to additional successes as we continue our financial transformation journey with Trintech."

Automation has not only reduced Serco's cost but also allows their team to focus on more value-added tasks. "Competition for talent is a big focus and challenge for many organizations today," continued Adams. "Automation can help retain your resources by allowing them to focus on value-added tasks instead of the manual, transactional processes."

Today, Serco is running 5,000 balance sheet reconciliations through Cadency on a monthly basis. In addition, they are auto-reconciling 15,000 accounts which has saved their team a total of 500 hours per month. To gain even further efficiencies, Serco also utilizes Trintech's pre-built Cadency SAP(R)-Certified Connector. "This connector automatically interfaces data flows from our SAP instance into Cadency so our team can begin analyzing it within minutes. Having the direct interface from SAP also gives confidence in the data matching between the two systems," continued Adams. From a reporting perspective, Serco's leadership team also now has full visibility into a Reporting dashboard that allows them to drill-down into any account and identify risk on the balance sheet.

Looking ahead, Serco is looking to continue to expand its automation strategy to gain further efficiencies across their processes. "If it is a repeatable process, the benefits of having technology doing it is far superior to any human. Automation is vital for process efficiency and cost-effectiveness," concluded Adams.

About Trintech

Trintech Inc., a pioneer of financial corporate performance management software, combines technical and financial expertise to create innovative, cloud-based software solutions that deliver world-class financial operations and insights. From high volume transaction matching and streamlining daily operational reconciliations, to automating and managing balance sheet reconciliations, intercompany accounting, journal entries, disclosure reporting and bank fee analysis, to governance, risk and compliance – Trintech's portfolio of financial solutions, including Cadency(R), Adra(R), and targeted tools, ReconNET(TM), T-Recs(R), and UPCS(R), help manage all aspects of the financial close process. Trintech's excellence in both innovation and client support have been recognized with a variety of awards over the years including most recently "Easiest to Do Business With" and "Fastest Implementation" in G2's Fall 2022 Report. Over 3,500 clients worldwide – including the majority of the Fortune 100 – rely on the company's cloud-based software to continuously improve the efficiency, reliability, and strategic insights of their financial operations.

Headquartered in Dallas, Texas, Trintech has offices located across the United States, United Kingdom, Australia, Singapore, France, Germany, Ireland, the Netherlands, and the Nordic countries, as well as strategic partners in South Africa, Latin America, and the Asia Pacific. To learn more about Trintech, visit www.trintech.com or connect with us on LinkedIn, Facebook and Twitter.

Media Contact:
Kelli Shoevlin
Sr. Manager, Global Corporate Marketing & Communications
kelli.shoevlin@trintech.com

SOURCE: Trintech, Inc.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Kitchen Culture Seeking Legal Advice on Validity of New Purported Notice to Remove 5 Directors; Urges Shareholders Not to Accept Notices or Proxy Forms Unquestioningly

SINGAPORE, Nov 3, 2022 – (ACN Newswire) – Kitchen Culture Holdings Ltd. ("Kitchen Culture" or the "Company") said today it will seek fresh legal advice on the validity of a letter from a law firm and fresh notice received by a group of 8 shareholders ("requisitioners") seeking to remove 5 of 6 directors via an Extraordinary General Meeting ("Second Intended EGM") proposed for 25 November 2022.

The directors of SGX Catalist-listed provider of solutions and products for kitchens and wardrobes received the new notice ("Second Concatenation Purported Notice") as well as a lawyer's letter yesterday. The requisitioners also published an advertisement for the Second Concatenation Purported Notice in The Business Times today.

OOWAY Group Ltd. ("OOWAY") – the Company's largest shareholder – and 7 individuals who own an aggregate of 21.71% of the Company's shares had issued Purported Notices under Section 177 of the Companies Act 1967 – on 30 September 2022 and 14 October 2022 – to remove the 5 directors. Kitchen Culture responded that the Purported Notices were defective and that any resolution passed on 1 November 2022 would be invalid.

Kitchen Culture's Board, with the exception of Madam Hao Dongting, has said that there are no grounds to justify the resignations of the 5 directors – Mr Lim Wee Li (Executive Director), Mr Lau Kay Heng (Non-Executive Director and Vice-Chairman), and 3 Independent Directors, Mr Ang Lian Kiat, Mr William Teo Choon Kow and Mr Peter Lim King Soon.

Mr Lau Kay Heng and Mr Peter Lim King Soon were named as new directors to on 15 July 2022, the same day that Mr Lincoln Teo, an OOWAY representative and former Interim CEO of Kitchen Culture, ceased to be Executive Director. The Company stressed that OOWAY had in fact supported the re-appointments of Mr William Teo Choon Kow and Mr Ang Lian Kiat at the Annual General Meeting held on 18 March 2022.

Addressing the letter and notices received yesterday from a law firm, which did not confirm for whom they were acting, Kitchen Culture said:

– The undated Second Concatenation Purported Notice contained resolutions for the proposed for Second Intended EGM scheduled for 25 November 2022 that were substantially similar to those proposed for the 1 November 2022 EGM that was 'postponed'. Yet it made no mention nor explained the so-called 'postponement' advertised by requisitioners on 29 October 2022 in The Business Times despite having issued a press release on 24 October 2022 urging shareholders to attend;

– As the above documents gave notice of the "Second Intended EGM" "to be convened and held only be electronic means" on 25 November 2022, it remains unclear if requisitioners have detracted from the "postponed" 1 November 2022 EGM which they had earlier urged shareholders to attend;

– The letter received from the law firm failed to explain how 2 earlier notices filed by requisitioners ahead of the earlier EGM (1 November 2022) can be "reissued" as a "composite" in the form of the Second Concatenation Purported Notice to call for the Second Intended EGM; and

– The requisitioners did not confirm whether the requisitioners regard the Second Intended EGM to be in anyway connected with the 1 November 2022 EGM that was called off.

The Company will seek to communicate with the requisitioners to minimise, if not to clear up, the confusion among shareholders which might have been caused by the requisitioners' actions or by the documents or omissions contained in the documents received yesterday.

Kitchen Culture urged shareholders in the meantime "NOT to accept unquestioningly the Second Concatenation Purported Notice of EGM or its related Proxy Form, or the validity the Second Intended EGM. Instead, they should await further announcements of the Company to give updates on this subject."

Kitchen Culture shares have been suspended from trading since July 2021. Its Board has seen several changes since the involvement of OOWAY in October 2020.

Issued by:
Kitchen Culture Holdings Ltd.
9 Raffles Place, #52-02, Republic Plaza
Singapore 048619
Tel: +65 6471 6776, Fax: +65 6472 6776

Media & Investor Contact
Whatsapp (Text): +65 9748 0688
kitchenculture@wer1.net

This press release has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this press release, including the correctness of any of the statements or opinions made or reports contained in this press release.

The contact person for the Sponsor is Ms. Lee Khai Yinn (Tel +65 6232 3210), at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542.

Kitchen Culture Holdings Ltd. [SGX: 5TI] [BBG: KCH:SP] [RIC: KCHL.SI] https://kcholdings.com.sg

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Kitchen Culture’s Extraordinary General Meeting (EGM) to be held on 25th November 2022, 9am

SINGAPORE, Nov 3, 2022 – (ACN Newswire) – Relevant Shareholders[1] of Kitchen Culture Holdings Ltd. today announced that the new Extraordinary General Meeting of the Company (EGM) will be convened on 25th November 2022 at 9am. The Live EGM Webcast and the Live EGM Audio Feed has been arranged in place of a physical EGM.

The Relevant Shareholders have informed the Company's Board on 2nd November 2022 in a letter of the same date of their intention to convene an EGM pursuant to Section 177 of the Companies Act[2]. The full notice of the EGM has been published on The Business Times on 3rd November 2022. The EGM seeks to remove 5 of Kitchen Culture's current Board of Directors and to appoint 5 new members to the Board. (See Annex A for details)

Shareholders who have pre-registered will be able to watch or listen to the EGM proceedings through the Live EGM Webcast or the Live EGM Audio Feed via mobile phone, tablet, computer or any such electronic device.

Details of the steps for pre-registration for the Live EGM Webcast or Live EGM Audio Feed, submission of substantial and relevant comments, queries and/or questions in advance of the EGM or through real-time electronic communication during the EGM, and voting live at the EGM by members themselves via real-time remote electronic voting or voting by appointing of a proxy(ies) or the Chairman of the EGM as proxy are set out in the Notice of EGM which has been published on The Business Times on 3rd November 2022.

All Shareholders including those who have bought shares using SRS monies must pre-register online at https://registration.ryt-poll.com/home/index/kchl-egm by 9.00 a.m. on Tuesday, 22nd November 2022 (being not less than 72 hours before the time appointed for holding the EGM) to enable verification of their status.

Following the verification and upon the closure of pre-registration, authenticated shareholders will receive email instructions to access the Live EGM Webcast and the Live EGM Audio Feed of the EGM proceedings by 9.00 a.m. on 24 November 2022 (being 24 hours before the time appointed for the holding of the EGM). The email instructions will contain the user ID, password details, and URL link to access the Live EGM Webcast and the Live EGM Audio Feed.

Reasons for changing to a new EGM date

The Relevant Shareholders of Kitchen Culture wish to highlight that the Company had previously refused to publish a Notice of EGM on SGXNet and on the Company's website, contrary to Catalist Rule 704(14) of the SGX Listing Manual ("Rule"). Under the Rule, the Company is required to immediately announce the details of any general meeting, such as publishing a copy of the Notice of the EGM on SGXNet and the Company's website regardless of any advice sought or action to be taken.

The failure to do so is a breach of the Rule and unfairly disenfranchises shareholders who wish to attend and exercise their vote at a general meeting.

The Relevant Shareholders[3] said,

By requisitioning for a new EGM date, we want to ensure that this time round, all shareholders of Kitchen Culture are given the opportunity to attend and vote at the EGM on 25th November 2022 (9:00am). Alternatively, those who are unable to attend the EGM can vote by proxy by 23rd November 2022 (9:00am).

As shareholders, they should have the right to decide who they wish to appoint to act in their interests as the directors of the Company.

We would like to thank all shareholders of Kitchen Culture who have supported our efforts thus far in the proposed appointment of our new board of directors, whom if elected, will make a significant difference in providing strong leadership and strategic direction to take the Company forward."

"We also wish to inform all shareholders that the requisitioning of the previous EGM, was in compliance with all relevant statutes/rules, but we decided to take the difficult (but correct) decision to postpone the EGM date to ensure that all shareholders can make informed decision and vote accordingly."

We have sought legal advice to review Article 71 of the Company's Articles of Association and was advised to reschedule the EGM, giving 21 days' notice to pre-empt any possible dispute on the length of the notice period."

[1] "Relevant Shareholders" refer to OOWAY Group Ltd., Koh Cher Chow, Lin Xiao Long, Ling Chui Chui, Koh Ngin Joo, Lim Cheng Huat, Chew Yu Sheng and Soh Koon Eng who together hold more than 10% of Kitchen Culture's issued share capital.
[2] Section 177 Notice constituting a special notice under Section 152(2) read with Section 185 of the Companies Act 1967 of Singapore (the "Companies Act") of the intention of the Relevant Shareholders to convene an extraordinary general meeting of the Company (the "EGM") pursuant to Section 177 of the Companies Act.
[3] See Annex B

Issued by Relevant Shareholders of Kitchen Culture Ltd.

Media and Investors Contact:
Email: query@oowayasia.com

Annex A: Extract of Agenda for EGM:

At the upcoming EGM, the 2 main agenda items among others to be raised are:
1. Removal of the following 5 Directors on the existing Board:
a. Mr. Lau Kay Heng
b. Mr. Lim Wee Li
c. Mr. William Teo Choon Kow
d. Mr. Ang Lian Kiat and
e. Mr. Peter Lim King Soon

2. Appointment of the following individuals to the Board:
a. Mr James Beeland Rogers, Jr. to be appointed as a Non-Executive Director of the Company;
b. Mr Yip Kean Mun to be appointed as an Executive Director of the Company;
c. Mr Lam Kwong Fai to be appointed as an Independent Director of the Company;
d. Mr Tan Meng Shern to be appointed as an Independent Director of the Company; and
e. Mr Cheung Wai Man to be appointed as an Independent Director of the Company.

This Notice of EGM has been advertised on 3rd November 2022, one English Language daily newspaper circulating in Singapore, namely The Business Times, pursuant to Article 71 of the Company's Constitution.

Printed copies of this Notice of EGM and Proxy Form will NOT be sent to members. Instead, these documents ought to be made available by the Company to shareholders solely by electronic means via publication on the Company's website and on the SGXNet.

Copies of the redacted curriculum vitae, Form 45 (Consent to Act as Director), confirmations of independence (where applicable) and Catalist Rules undertakings of these new directors proposed to be appointed to the board will be made accessible at these links:

Link 1: https://drive.google.com/drive/u/0/mobile/folders/1iEag3gqRV_OAMPuErTOrWmTsji4KRyvp?usp=sharing
Link 2: https://tinyurl.com/5bkvtepr

Annex B: Notice to Company

The Relevant Shareholders have also informed the Kitchen Culture Board that prior to the conclusion of the EGM, the Company, including the current Directors of the Company, should not:

1. Take any action to effect any casual appointment of Director(s) or action that will affect the number of existing issued shares of the Company or carry out any corporate action that is dilutive in nature to the minority shareholders of the Company;
2. Carry out any transaction that would result in the divestment or acquisition of any business interest or asset for or on behalf of the Company;
3. Enter into any transaction committing or exposing the Company to any potential liability of a significant nature.

Kitchen Culture Holdings Ltd. [SGX: 5TI] [BBG: KCH:SP] [RIC: KCHL.SI] https://kcholdings.com.sg

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

WestCann Commercializes Reconstituted Cannabis

Perth, Australia, Vancouver, British Columbia and Greenville, North Carolina, Nov 3, 2022 – (ACN Newswire) – WestCann Holdings Ltd. (“WCH” or the “Company”) is pleased to announce that it has signed an agreement with IOTO USA, LLC (“IOTO”) for the exclusive global licensing of all uses with cannabis and hemp of IOTO’s patented technologies for the reconstitution of plant matter.

Originally developed for the primary processing of tobacco, IOTO’s technologies allow for complete homogenization of cannabis as well as for full process control over the active ingredients and smoking characteristics. As a result, precision tobacco cigarette making and packaging equipment can be utilized for pre-roll manufacturing, creating a highly consistent and reproducible consumer product with significant quality and cost advantages.

The Company’s wholly owned subsidiary WestCann Processors Inc. is planning to start the manufacturing of reconstituted cannabis pre-rolls for the Canadian recreational market at its Yorkton, SK facility by December 2022 and expects its products to be available to consumers through licensed retail stores in early 2023.

CEO Andreas Gedeon: “I’m convinced that our products will be disruptive to the existing pre-roll market, which is one of the single biggest growing segments in the cannabis industry. I believe that consumers will quickly appreciate our convenient format and the fact that they can always get the same experience with the next pack they purchase, all at a discount to what they are used to paying right now.”

The exclusive license to IOTO’s technologies complements WestCann’s portfolio of custom engineered automatization solutions, including its patented child resistant hinge lid pack that is certified for use in Canada, the U.S., Switzerland and the EU.

Over the course of the next year, the Company plans on partnering with licensed operations in several U.S. states for additional installations of its fully automated pre-roll making and packing lines, as well as on preparing to be a first mover in the upcoming recreational cannabis markets in Germany and Thailand.

For further information please visit www.westcann.com or contact Andreas Gedeon, CEO at andreas@westcann.com.

About WestCann

WestCann Holdings Ltd., based in Perth, WA and its wholly owned subsidiaries WestCann Processors Inc, 102021671 Saskatchewan Inc. in Canada and Laika Brands, LLC in Nevada are focusing on the transfer of tobacco processing technologies to the recreational cannabis markets. For more information on WestCann please visit www.westcann.com.

About IOTO

IOTO USA, LLC, a subsidiary of IOTO International in Brazil, is a global leader in the provision of flavorings and reconstitution technologies for tobacco. For more information on IOTO please visit www.iotointernational.com.

PRESS RELEASE CONTACT
Andreas Gedeon
+1 (250) 713-6302
andreas@westcann.com

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Hong Kong SAR Chief Executive shares his vision for Hong Kong with UK business community at virtual dialogue

HONG KONG, Nov 2, 2022 – (ACN Newswire) – To strengthen the longstanding economic and trade relationship between Hong Kong and the United Kingdom (UK), a virtual dialogue with the Chief Executive of the Hong Kong Special Administrative Region (HKSAR), Mr John Lee, was held to engage with the business community in the UK on 2 November, hosted by the Hong Kong Trade Development Council (HKTDC).


Margaret Fong, HKTDC Executive Director; Dr Peter KN Lam, HKTDC Chairman; John Lee, Chief Executive of the Hong Kong Special Administrative Region and Peter Burnett, Immediate Past Chairman of the British Chamber of Commerce in Hong Kong [L-R]


Moderated by the British Chamber of Commerce in Hong Kong Immediate Past Chairman, Mr Peter Burnett, the dialogue served as a unique opportunity for UK businesses to interact with the HKSAR Chief Executive and hear first-hand updates on the latest policy initiatives to strengthen Hong Kong and new opportunities for the international business community, just weeks after the Chief Executive delivered his first Policy Address.

In his opening address, Mr. Lee underlined Hong Kong's established strengths and arising opportunities, and what the city can offer to help UK and international businesses take off or expand in Asia. He highlighted the longstanding and enduring business ties between Hong Kong and the UK, "thanks not just to our friendship, but also, very importantly, to our common law legal system, the rule of law and our independent judicial power. Thanks also to our strong support and beliefs for free trade and our strong footholds in professional services".

The Chief Executive remarked that the UK is Hong Kong's top trading partner in Europe, while Hong Kong is the UK's second-largest trading partner in Asia. Merchandise trade between the two places in 2021 totalled US$ 17.7 billion, up more than 25% year-on-year.

He added that in 2021, more than GBP7 billion merchandise trade between the UK and Mainland China was routed through Hong Kong. "That speaks, loud and clear, of Hong Kong's unique status as the business gateway connecting China with the rest of the world. This enviable role is guaranteed through one country, two systems," he said.

While COVID-19 has impacted growth in Hong Kong, Mr Lee stated "it is the economy amidst challenges posed by the pandemic we are planning for now". He emphasised Hong Kong's long-term growth in the national strategies, which include the Belt and Road Initiative, Guangdong-Hong Kong-Macao Greater Bay Area (GBA) and 14th Five-Year Plan. He mentioned HKTDC's ongoing work to set up GoGBA Business Support Centres covering all nine GBA cities in Mainland China to offer business information in both English and Chinese available to all.

In his opening remarks, HKTDC Chairman Dr Peter Lam said: "One huge opportunity is the vast Mainland China market, with a focus on the southern part of the country, known as the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). It boasts a market of 86 million with a GDP of US$ 1.74 trillion, comparable to that of South Korea and Canada. ASEAN has been a key focus for many international companies. It offers even greater prospects, as new trade cooperation agreements, such as the Regional Comprehensive Economic Partnership (RCEP), come into operation. To capitalise on the many opportunities, Hong Kong is your ideal springboard".

The Chief Executive also fielded questions from the UK business community, covering a range of topics, including easing of COVID-19 restrictions, Hong Kong's economic outlook, closer government-business cooperation, talent attraction and more. He underscored the importance of innovation and technology (I&T) to Hong Kong's future, the Northern Metropolis and plans to welcome at least 35,000 targeted professionals to Hong Kong each year.

The event attracted more than 600 business leaders, with the majority from the UK. This followed a trip to the UK by Dr Lam and Ms Margaret Fong, HKTDC Executive Director, in October to meet UK business leaders, as part of the HKTDC's initiative to promote business opportunities in Hong Kong to the global business community.

Photos Download: https://bit.ly/3h4GEe9

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.

Media enquiries
Please contact the HKTDC's Communications and Public Affairs Department:
Sunny Ng, Tel: +852 2584 2357, Email: sunny.sl.ng@hktdc.org
Clementine Cheung, Tel: +852 2584 4514, Email: clementine.hm.cheung@hktdc.org

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com